In this podcast, Steering Commitment Member Rakesh Jain, MD, MPH, answers pressing questions about the addictive potential of GABA agonist interventions, how exercise can help patients with major depressive...
Ben Medrano, MD, and Michael J Verbora, MD, MBA discuss what patient populations are benefiting most from intravenous (IV) ketamine treatment and what populations could be potentially harmed by the...
Ben Medrano, MD, and Michael J Verbora, MD, MBA discuss what patient populations are benefiting most from intravenous (IV) ketamine treatment and what populations could be potentially harmed by the...
In this podcast, Nolan R. Williams, MD, discusses the Stanford Accelerated Intelligent Neuromodulation Therapy protocol, which reduced severe depression symptoms in 90% of participants in a small trial.
...
In this Q&A, lead author Shahina Pardhan, PhD, discusses her study that found dual sensory impairment is associated with increased depression and anxiety, with women showing stronger associations than...
Dr Jennifer Dwyer discusses the results from her randomized, double-blind, placebo-controlled crossover trial study that found a reduction in depression scores at 24 hours post treatments with ketamine...
In this video, Charles Conway, MD, summarizes new research supporting the use of nitrous oxide for the treatment of treatment-resistant major depression (TRMD).
In part 2 of this video, Charles Conway, MD, covers possible side effects of the use of nitrous oxide for the treatment of treatment-resistant major depression , and next steps for continued research....
